Bin Liu

7PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 01, 2026
A CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial.

|Jun 25, 2026
FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer.

|Mar 28, 2025
Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy.

Michael S Oh, Jensen Abascal, Austin K Rennels

|Nov 19, 2024
Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer.

Michael S Oh, Camelia Dumitras, Ramin Salehi-Rad

|Sep 26, 2024
Hyper-Interferon Sensitive Influenza Induces Adaptive Immune Responses and Overcomes Resistance to Anti-PD-1 in Murine Non-Small Cell Lung Cancer.

Yushen Du, Ramin Salehi-Rad, Tian-Hao Zhang

|Jun 10, 2024
Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA Methylome.

Shuo Li, Wenyuan Li, Bin Liu

Pageof 2

Frequent Collaborators

5 joint publications

Ramin Salehi-Rad

4 joint publications

Steven M Dubinett

3 joint publications

Michael S Oh

3 joint publications

Linh M Tran